The objective of the Preclinical Development Program (PDEV) is to accelerate completion of preclinical development, FDA IND clearance, and clinical trial startup for stem cell-based and genetic ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

South San Francisco, CA, April 24, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved awarding ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

研究目标：本项目将探究高可信度神经精神疾病风险蛋白的相互作用、分布和功能，并识别患者基因变异的趋同病理生物学 ...

Objetivo de la investigación Un nuevo tipo de APC sirve a los pacientes mayores como 1) mejor MSC en inmunomodulación (reducción de la inflamación) para el ...

Candidato terapéutico o dispositivo Plurocart consiste en condrocitos derivados de células madre pluripotentes, sembrados en un armazón; está destinado a tratar el cartílago dañado en la articulación ...

Genome sequencing in the clinic often allows patients to receive a molecular diagnosis. However, variants are most often evaluated for pathogenicity, neglecting potential treatability and thus often ...

X-linked lymphoproliferative disease (XLP1) results from SH2D1A gene mutations affecting the SLAM-associated protein (SAP). A regulated lentiviral vector (LV), XLP-SMART LV, designed to express SAP at ...

The Sanford Burnham Prebys Institute’s third cohort of Summer Program to Accelerate Regenerative medicine Knowledge (SPARK) interns were comprised of young scholars representing the diversity of ...

Objetivo de la investigación Células CAR-iNKT (AlloMCAR-iNKT) dirigidas a mesotelina alogénica diseñada por HSC Impacto en el tratamiento del cáncer de ovario Principales actividades propuestas Hito 1 ...